GB201916238D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB201916238D0
GB201916238D0 GBGB1916238.7A GB201916238A GB201916238D0 GB 201916238 D0 GB201916238 D0 GB 201916238D0 GB 201916238 A GB201916238 A GB 201916238A GB 201916238 D0 GB201916238 D0 GB 201916238D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1916238.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inflazome Ltd
Original Assignee
Inflazome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inflazome Ltd filed Critical Inflazome Ltd
Priority to GBGB1916238.7A priority Critical patent/GB201916238D0/en
Publication of GB201916238D0 publication Critical patent/GB201916238D0/en
Priority to JP2022525955A priority patent/JP2023501334A/en
Priority to CN202080074261.1A priority patent/CN114599356A/en
Priority to EP20803798.6A priority patent/EP4054564A1/en
Priority to US17/775,230 priority patent/US20220409585A1/en
Priority to PCT/EP2020/081290 priority patent/WO2021089782A1/en
Ceased legal-status Critical Current

Links

GBGB1916238.7A 2019-11-07 2019-11-07 Novel treatment Ceased GB201916238D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1916238.7A GB201916238D0 (en) 2019-11-07 2019-11-07 Novel treatment
JP2022525955A JP2023501334A (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory diseases
CN202080074261.1A CN114599356A (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory disorders
EP20803798.6A EP4054564A1 (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory disorders
US17/775,230 US20220409585A1 (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory disorders
PCT/EP2020/081290 WO2021089782A1 (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1916238.7A GB201916238D0 (en) 2019-11-07 2019-11-07 Novel treatment

Publications (1)

Publication Number Publication Date
GB201916238D0 true GB201916238D0 (en) 2019-12-25

Family

ID=69062153

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1916238.7A Ceased GB201916238D0 (en) 2019-11-07 2019-11-07 Novel treatment

Country Status (1)

Country Link
GB (1) GB201916238D0 (en)

Similar Documents

Publication Publication Date Title
GB201813876D0 (en) Treatment
GB201916237D0 (en) Novel treatment
GB201800274D0 (en) Novel treatments
IL288937A (en) Improved treatment using eyp001
GB201900702D0 (en) Therapy
IL281792A (en) Treatment methods
GB201800546D0 (en) Treatment
IL281839A (en) Treatment methods
GB201914296D0 (en) Treatment
GB201916754D0 (en) Novel treatment
GB201916239D0 (en) Novel treatment
GB201916238D0 (en) Novel treatment
GB201916236D0 (en) Novel treatment
GB201916235D0 (en) Novel treatment
GB201916234D0 (en) Novel treatment
GB201913988D0 (en) Novel treatment
GB201912760D0 (en) Treatment
GB201912365D0 (en) Treatment
GB201912335D0 (en) Treatment
GB201911816D0 (en) Treatment
GB201911603D0 (en) Treatment
GB201910755D0 (en) Treatment
GB201904253D0 (en) Treatment
GB201902580D0 (en) Treatment
GB201902578D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)